These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 3993242

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT, Yildirim U, Zorlu F, Ozen H.
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [Abstract] [Full Text] [Related]

  • 23. A second-look TUR in T1 transitional cell carcinoma: why?
    Jakse G, Algaba F, Malmström PU, Oosterlinck W.
    Eur Urol; 2004 May; 45(5):539-46; discussion 546. PubMed ID: 15082193
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Cystectomy or transurethral resection in the treatment of bladder carcinoma].
    Flamm J, Kiesswetter H, Burkert S.
    Z Urol Nephrol; 1982 Oct; 75(10):729-37. PubMed ID: 7158092
    [Abstract] [Full Text] [Related]

  • 28. Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience.
    Gupta NP, Saini AK, Dogra PN, Seth A, Kumar R.
    BJU Int; 2011 Aug; 108(4):553-6. PubMed ID: 21176081
    [Abstract] [Full Text] [Related]

  • 29. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, Chung J, Lee KH.
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [Abstract] [Full Text] [Related]

  • 30. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC.
    Anticancer Res; 1998 Dec; 18(6B):4717-21. PubMed ID: 9891547
    [Abstract] [Full Text] [Related]

  • 31. [Tumors of the bladder in women. Epidemiologic and therapeutic aspects. Apropos of 40 cases].
    Rabii R, el Moussaoui A, Rais H, Joual A, Debbagh A, el Mrini M, Benjelloun S.
    Ann Urol (Paris); 1998 Dec; 32(3):166-71. PubMed ID: 9657034
    [Abstract] [Full Text] [Related]

  • 32. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC, Chang TH, Wu WJ, Ke HL, Huang SP, Tsai PC, Chang SJ, Shen JT, Chou YH, Huang CH.
    Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
    [Abstract] [Full Text] [Related]

  • 33. [The holmium laser in the treatment of bladder cancer patients].
    Mazo EB, Chepurov AK.
    Urol Nefrol (Mosk); 1996 Nov; (4):34-5. PubMed ID: 8928348
    [Abstract] [Full Text] [Related]

  • 34. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [Abstract] [Full Text] [Related]

  • 35. [Frequency of recurrences and tumor progression on superficial bladder carcinoma (author's transl)].
    Rübben H, Dahm HH, Lutzeyer W.
    Urologe A; 1981 Jul; 20(4):211-4. PubMed ID: 7196631
    [Abstract] [Full Text] [Related]

  • 36. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
    Kriegmair M, Waidelich R, Baumgartner R, Lumper W, Ehsan A, Hofstetter A.
    Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
    [Abstract] [Full Text] [Related]

  • 37. [Recurrent and up-grading bladder cancer in a young female: a case report].
    Ouchi H, Noguchi S, Masuda M, Yao M, Kubota Y, Hosaka M.
    Hinyokika Kiyo; 1996 Apr; 42(4):311-3. PubMed ID: 8693967
    [Abstract] [Full Text] [Related]

  • 38. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K, Chihara Y, Kondo H, Hirao Y.
    Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
    [Abstract] [Full Text] [Related]

  • 39. [The significance of urine cytology three consecutive days after transurethral resection as a predictor of superficial bladder cancer recurrence].
    Yumura Y, Takase K, Kato Y, Hamano A, Mikata K, Ogo Y, Noguchi S, Satomi Y.
    Hinyokika Kiyo; 2004 Mar; 50(3):171-6. PubMed ID: 15148768
    [Abstract] [Full Text] [Related]

  • 40. [Urethral recurrence after cysto-prostatectomy for bladder tumor].
    Robert M, Burgel JS, Serre I, Guiter J, Grasset D.
    Prog Urol; 1996 Mar; 6(4):558-63. PubMed ID: 8924933
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.